Allergy affects many children and adults around the world but most people aren’t diagnosed and even a lower percentage is diagnosed correctly. For these reasons Allergy is considered one of the most common and undertreated health issues in the world and better diagnosis is needed.

Gamidor Diagnostics is the representative of Phadia, Thermo Scientific, a leading company who develops, manufactures and markets complete blood test systems for the clinical diagnosis of allergy, asthma and autoimmune diseases. It is considered the Golden Standard for in vitro Specific IgE testing.
The company’s product line include automated platforms and assays for specific IgE tests for over 600 allergens, total IgE, Tryptase, specific IgG and IgG4 tests.

A new concept of testing, now introduced in Israel by Gamidor, is Molecular Allergy testing. Molecular Allergy can be tested on the Phadia instruments or a Phadia’s multiplex platform – ImmunoCAP ISAC.
Molecular Allergy tests allow to identify components in the allergen source and to distinguish between specific and cross-reactive components in order to improve risk assessment and patient management.
ImmunoCAP® ISAC is a highly advanced tool for revealing the patient’s IgE antibody profile. This advanced technology enables a simultaneous measurement of IgE antibodies to a fixed panel of 112 components from 51 allergen sources in a single step, using only 30 ul of serum or plasma.